Libra Infusions Limited (DSE:LIBRAINFU)
616.00
-11.00 (-1.75%)
At close: Mar 8, 2026
Libra Infusions Ratios and Metrics
Market cap in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | Current | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | 2014 - 2010 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Jun '19 Jun 30, 2019 | Jun '18 Jun 30, 2018 | Jun '17 Jun 30, 2017 | Jun '16 Jun 30, 2016 | Jun '15 Jun 30, 2015 | 2014 - 2010 |
| Market Capitalization | 1,404 | 1,310 | 1,534 | 653 | 760 | 422 | Upgrade
|
| Market Cap Growth | -24.38% | -14.61% | 134.73% | -14.00% | 80.01% | -19.29% | Upgrade
|
| Enterprise Value | - | 2,195 | 2,420 | 1,531 | 1,664 | 1,270 | Upgrade
|
| Last Close Price | 623.10 | 579.08 | 678.16 | 287.16 | 332.21 | 183.29 | Upgrade
|
| PE Ratio | 886.13 | 826.64 | 266.35 | 107.37 | 130.53 | 97.96 | Upgrade
|
| PS Ratio | 7.12 | 6.65 | 8.04 | 2.68 | 3.19 | 1.47 | Upgrade
|
| PB Ratio | 0.74 | 0.69 | 0.81 | 0.33 | 0.39 | 0.21 | Upgrade
|
| P/TBV Ratio | 0.74 | 0.69 | 0.81 | 0.33 | 0.39 | 0.21 | Upgrade
|
| P/FCF Ratio | - | - | 4989.40 | - | 12.69 | - | Upgrade
|
| P/OCF Ratio | 95.70 | 89.27 | 361.55 | 297.60 | 10.74 | 46.56 | Upgrade
|
| EV/Sales Ratio | - | 11.14 | 12.69 | 6.27 | 6.99 | 4.43 | Upgrade
|
| EV/EBITDA Ratio | - | 76.27 | 104.12 | 59.25 | 58.04 | 21.72 | Upgrade
|
| EV/EBIT Ratio | - | 98.82 | 149.21 | 79.55 | 73.67 | 24.36 | Upgrade
|
| EV/FCF Ratio | - | - | 7871.68 | - | 27.80 | - | Upgrade
|
| Debt / Equity Ratio | 0.48 | 0.48 | 0.48 | 0.46 | 0.46 | 0.48 | Upgrade
|
| Debt / EBITDA Ratio | 31.80 | 31.80 | 38.94 | 34.97 | 31.80 | 16.20 | Upgrade
|
| Debt / FCF Ratio | - | - | 2943.56 | - | 15.24 | - | Upgrade
|
| Net Debt / Equity Ratio | 0.47 | 0.47 | 0.47 | 0.45 | 0.45 | 0.48 | Upgrade
|
| Net Debt / EBITDA Ratio | 31.30 | 31.30 | 38.55 | 34.59 | 30.68 | 16.04 | Upgrade
|
| Net Debt / FCF Ratio | -171.93 | -171.93 | 2914.24 | -68.08 | 14.70 | -12.07 | Upgrade
|
| Asset Turnover | 0.05 | 0.05 | 0.04 | 0.05 | 0.05 | 0.08 | Upgrade
|
| Inventory Turnover | 1.59 | 1.59 | 1.54 | 2.21 | 1.78 | 1.60 | Upgrade
|
| Quick Ratio | 0.22 | 0.22 | 0.03 | 0.03 | 0.03 | 0.03 | Upgrade
|
| Current Ratio | 0.65 | 0.65 | 0.95 | 0.94 | 0.94 | 0.94 | Upgrade
|
| Return on Equity (ROE) | 0.08% | 0.08% | 0.30% | 0.31% | 0.29% | 0.22% | Upgrade
|
| Return on Assets (ROA) | 0.36% | 0.36% | 0.22% | 0.26% | 0.31% | 0.86% | Upgrade
|
| Return on Invested Capital (ROIC) | 0.56% | 0.56% | 0.43% | 0.49% | 0.47% | 1.00% | Upgrade
|
| Return on Capital Employed (ROCE) | 0.80% | 0.80% | 0.60% | 0.70% | 0.80% | 1.90% | Upgrade
|
| Earnings Yield | 0.11% | 0.12% | 0.38% | 0.93% | 0.77% | 1.02% | Upgrade
|
| FCF Yield | -0.37% | -0.40% | 0.02% | -2.01% | 7.88% | -18.41% | Upgrade
|
| Dividend Yield | - | 0.06% | - | 0.58% | 0.42% | 0.61% | Upgrade
|
| Payout Ratio | 0.58% | 0.58% | 33.93% | 23.04% | 28.24% | 16.96% | Upgrade
|
| Total Shareholder Return | - | 0.06% | - | 0.58% | 0.42% | 0.61% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.